Pharvaris N.V. (PHVS)
NASDAQ: PHVS · IEX Real-Time Price · USD
23.35
+0.58 (2.55%)
At close: Apr 26, 2024, 4:00 PM
24.60
+1.25 (5.35%)
After-hours: Apr 26, 2024, 4:03 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.26 billion as of April 26, 2024. Its market cap has increased by 338.46% in one year.
Market Cap
1.26B
Enterprise Value
838.39M
1-Year Change
338.46%
Ranking
Category
Stock Price
$23.35
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.26B, an increase of 97.33%. That is a compound annual growth rate of 23.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 1.22B | 2.55% |
Apr 25, 2024 | 1.19B | 7.15% |
Apr 24, 2024 | 1.11B | -0.19% |
Apr 23, 2024 | 1.11B | 2.02% |
Apr 22, 2024 | 1.09B | 8.92% |
Apr 19, 2024 | 1.00B | 4.02% |
Apr 18, 2024 | 963.20M | -13.12% |
Apr 17, 2024 | 1.11B | 0.96% |
Apr 16, 2024 | 1.10B | 4.22% |
Apr 15, 2024 | 1.05B | -8.00% |
Apr 12, 2024 | 1.15B | -1.83% |
Apr 11, 2024 | 1.17B | 0.18% |
Apr 10, 2024 | 1.16B | 22.79% |
Apr 9, 2024 | 948.40M | 1.76% |
Apr 8, 2024 | 932.00M | 0.80% |
Apr 5, 2024 | 924.60M | 0.58% |
Apr 4, 2024 | 919.30M | 0.63% |
Apr 3, 2024 | 913.50M | 0.63% |
Apr 2, 2024 | 907.80M | 2.36% |
Apr 1, 2024 | 886.90M | -6.36% |
Mar 28, 2024 | 947.10M | -1.66% |
Mar 27, 2024 | 963.10M | -0.80% |
Mar 26, 2024 | 970.90M | 11.43% |
Mar 25, 2024 | 871.30M | -12.70% |
Mar 22, 2024 | 998.00M | -2.60% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Brookdale Senior Living | 1.32B |
Day One Biopharmaceuticals | 1.30B |
Omnicell | 1.28B |
Soleno Therapeutics | 1.27B |
Kiniksa Pharmaceuticals | 1.26B |
Ligand Pharmaceuticals | 1.25B |
Xencor | 1.23B |
Pacira BioSciences | 1.22B |